(2020) Bevacizumab/carboplatin/paclitaxel. Reactions Weekly, 1812 (1) 57 doi:10.1007/s40278-020-80536-8
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Bevacizumab/carboplatin/paclitaxel | ||
Journal | Reactions Weekly | ||
Year | 2020 (July) | Volume | 1812 |
Issue | 1 | ||
Publisher | Springer Science and Business Media LLC | ||
DOI | doi:10.1007/s40278-020-80536-8Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13404293 | Long-form Identifier | mindat:1:5:13404293:2 |
GUID | 0 | ||
Full Reference | (2020) Bevacizumab/carboplatin/paclitaxel. Reactions Weekly, 1812 (1) 57 doi:10.1007/s40278-020-80536-8 | ||
Plain Text | (2020) Bevacizumab/carboplatin/paclitaxel. Reactions Weekly, 1812 (1) 57 doi:10.1007/s40278-020-80536-8 | ||
In | (2020, July) Reactions Weekly Vol. 1812 (1) Springer Science and Business Media LLC |
See Also
These are possibly similar items as determined by title/reference text matching only.
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |